STEPHEN C MCCLUSKI
CIK 1188728 · Senior Vice President · last filed 2025-08-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$372.3K
Companies
5
Total Filings
63
Lifetime Open-Market Net
-$1.86M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNRO | Director | 31,928 | $11.66 | $372.3K | -$1.86M | 17 | 2025-08-13 |
| ImmunoGen, Inc. (IMGN) Delisted | Director | 0 | $31.23 | $0 | $0 | 20 | 2024-02-12 |
| STANDARD MICROSYSTEMS CORP (SMSC) Delisted | Director | 4,867 | — | — | $0 | 17 | 2012-07-18 |
| IDEV | Director | 0 | $92.97 | $0 | $0 | 3 | 2009-02-25 |
| BAUSCH & LOMB INC (BOL) Delisted | Senior Vice President | 26,049 | — | — | $0 | 4 | 2007-05-10 |
Recent Filings · Page 2 of 7
63 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-10 | MNRO | Mixed | — | -$8.7K | EDGAR |
| 2021-06-17 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-20 | MNRO | Grant (A) | +2,575 | $0 | EDGAR |
| 2020-06-18 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-15 | MNRO | Grant (A) | +1,661 | $0 | EDGAR |
| 2019-06-24 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-19 | MNRO | Mixed | — | -$261.0K | EDGAR |
| 2018-08-16 | MNRO | Grant (A) | +1,828 | $0 | EDGAR |
| 2018-06-22 | ImmunoGen, Inc. (IMGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-05 | MNRO | Mixed | — | -$110.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.